Quantcast
Last updated on April 18, 2014 at 1:21 EDT

Latest Prostate cancer Stories

2014-03-07 12:26:01

Arizona radiology group raises awareness of potentially lifesaving program SCOTTSDALE, Ariz., March 7, 2014 /PRNewswire/ -- Scottsdale Medical Imaging (SMIL) has launched a new website, www.checkmylungs.com, in support of a groundbreaking lung cancer screening program and to raise awareness of the importance of early detection. The new Check My Lungs website is designed and programmed to be a unique lung cancer screening resource for patients and physicians. This innovative site...

2014-03-07 08:25:40

BETHESDA, Md., March 7, 2014 /PRNewswire/ -- Northwest Biotherapeutics (NASDAQ: NWBO) (NW Bio), a biotechnology company developing DCVax® personalized immune therapies for solid tumor cancers, announced today, in response to shareholder inquiries, that the Data Safety Monitoring Board (DSMB) has made an unblinded review of the safety data for the Company's ongoing international Phase III GBM Trial, and has recommended that the trial continue as planned....

2014-03-07 08:25:29

SYDNEY, March 7, 2014 /PRNewswire/ -- Viralytics Limited (ASX:VLA, OTC:VRACY) will present at two prominent U.S. healthcare investment conferences next week. CEO Dr Malcolm McColl will present on March 10 at the 26th Annual ROTH Investment Conference in Dana Point, California. The ROTH conference is one of the largest of its kind in the U.S. with approximately 3,000 attendees including 1,000 from the global investment community. On March 12 Dr. McColl will present at the Bernstein Emerging...

2014-03-06 23:23:25

Genomic Health Successfully Launched a Viral Educational Concept for Reaching People Touched by Breast Cancer Titled “Pass It On, Until Every Woman Knows” Indianapolis, IN (PRWEB) March 06, 2014 The Diagnostics Marketing Association (DxMA) announced today its 2013 Marketer of the Year: Genomic Health. This award recognizes diagnostic industry innovation by marketers in highlighting their company and/or products and will be presented during the annual DxMA Global Marketing Summit to...

2014-03-06 13:13:25

Ludwig researchers show that infecting just 1 tumor with a virus could boost the systemic effectiveness of cancer immunotherapy A Ludwig Cancer Research study suggests that the clinical efficacy of checkpoint blockade, a powerful new strategy to harness the immune response to treat cancers, might be dramatically improved if combined with oncolytic virotherapy, an investigational intervention that employs viruses to destroy tumors. Published today in the journal Science Translational...

2014-03-06 08:30:07

AVEED offers distinct dosing schedule to increase testosterone levels in hypogonadal men, and underscores Endo's strategy and commitment to addressing health issues facing men DUBLIN, March 6, 2014 /PRNewswire/ -- Endo International plc (NASDAQ: ENDP) (TSX: ENL) announced today that its operating company Endo Pharmaceuticals Inc. received U.S. Food and Drug Administration (FDA) approval of AVEED(TM) (testosterone undecanoate) injection for the treatment of adult men with hypogonadism...

2014-03-05 23:25:20

Diabetic patients who develop bladder cancer after taking the drug Actos (pioglitazone) tend to have about the same number of Stage I, II, and III cancers as surgical patients who never used Actos. Raleigh, NC (PRWEB) March 05, 2014 A new published study of patients who had their bladders removed because of cancer suggests that the drug Actos may not have much effect on the growth and extent of cancer. As Cancer Monthly reports, the study, published in BMC Urology, examined the cases of...

2014-03-05 11:06:28

Researchers have discovered a link between prostate cancer aggressiveness and the accumulation of a compound produced when cholesterol is metabolized in cells, findings that could bring new diagnostic and treatment methods. Findings also suggest that a class of drugs previously developed to treat atherosclerosis might be repurposed for treatment of advanced prostate cancer. The research showed depletion of the compound cholesteryl ester significantly reduced prostate cancer cell...

2014-03-05 11:01:37

Johns Hopkins researchers identify set of genes that can be turned back on and potentially allow for more effective treatment Johns Hopkins researchers say they have identified a set of genes that appear to predict which tumors can evade detection by the body's immune system, a step that may enable them to eventually target only the patients most likely to respond best to a new class of treatment. Immune therapy for ovarian, breast and colorectal cancer — treatments that encourage the...

2014-03-05 08:29:16

Lung, Prostate, and Brain Cancer Patients Receive Edge Radiosurgery at Champalimaud Center for the Unknown LISBON, Portugal, March 5, 2014 /PRNewswire/ -- Doctors at the Champalimaud Center for the Unknown here have performed the world's first cancer treatments using the new advanced Edge(TM) radiosurgery system from Varian Medical Systems (NYSE: VAR). This fast, precise and non-invasive alternative to conventional surgery was used to treat several patients with lung, prostate and...